Efficacy endpoints | n [%] |
---|---|
ETF | 0 |
LCF | 0 |
LPF | 2a |
ACPR | 69 [97.2%] |
Total patients at baseline | 88 |
PP PCR uncorrected cure rate | 97.2% (95% CI 90.2–99.7%) |
PP PCR corrected cure rate | 98.6% (95% CI 92.3–100%) |
K-M PCR uncorrected cure rate | 97.5% (95% CI 90.5–99.4) |
K-M PCR corrected cure rate | 98.7% (95% CI 91.4–99.8) |